Active-phase labor arrest: oxytocin augmentation for at least 4 hours

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Clinical Obstetrics

Background:

• Active-phase labor arrest is a common indication for cesarean delivery.
• Current protocols often involve shorter periods of oxytocin augmentation before surgical intervention.

Purpose of the Study:

• To evaluate the efficacy and safety of a labor management protocol mandating a minimum of 4 hours of oxytocin augmentation for active-phase labor arrest.
• To determine the impact of extended oxytocin augmentation on vaginal delivery rates.

Main Methods:

• Prospective evaluation of term gravidas with active-phase labor arrest (≥4 cm dilation, ≤1 cm progress in 2 hours).
• Exclusion of nonvertex presentations, prior cesareans, multiple gestations, and nonreassuring fetal heart rate or chorioamnionitis.
• Oxytocin augmentation aimed for >200 Montevideo units; cesarean delivery withheld until ≥4 hours of adequate contractions or ≥6 hours of oxytocin.

Main Results:

• 92% of 542 women managed under the protocol delivered vaginally.
• Subsequent vaginal delivery rates after 4 hours of oxytocin were 88% for parous and 56% for nulliparous women.
• No severe maternal complications were reported; neonatal outcomes were favorable.

Conclusions:

• Extending oxytocin augmentation to a minimum of 4 hours for active-phase labor arrest is effective and safe.
• This protocol significantly enhances vaginal delivery success rates.
• The findings support a revised approach to managing labor arrest, prioritizing conservative measures.